Biotech

All Articles

Galapagos pauses CAR-T cell treatment trial over Parkinsonism scenario

.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushi...

James Wilson leaving Penn to release 2 brand new biotechs

.After much more than thirty years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leavin...

3 biotechs attempt to beat the summer months warmth through dropping team

.As biotechs attempt to turn a new web page in August, a minimum of 3 providers have actually lost s...

venBio lifts $528M for fifth life sciences VC fund

.Expert equity capital agency venBio has actually elevated one more half a billion bucks to purchase...

Otsuka pays out $800M for Jnana as well as its own clinical-stage PKU drug

.Otsuka Pharmaceutical has actually gotten Boston-based Jnana Rehabs for $800 thousand so the Easter...

FibroGen gives up 75% of US workers as resource flunks 2 additional trials

.FibroGen is actually substantially reorganizing its organization, laying off 75% of its own U.S. pe...

Tracon unwind full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has chosen to wind down functions weeks after an injectable invulnerable che...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy medication, promotes FDA run

.Our company actually understand that Takeda is actually hoping to discover a pathway to the FDA for...

VBI Vaccinations declare personal bankruptcy, finds asset sale

.Immunology biotech VBI Vaccinations is veering alarmingly near the climax, with plans to file for p...